Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis (vol 45, pg 883, 2007)
P. G. Pappas, Dn Buell, B Dupont, Ll Kovanda, DL Horn, Deepak Talwar, Raghunadharao Digumarti(Heidelberg University), Ac Reboli, C. M. F. Rotstein(Hamilton Health Sciences), Luis Ostrosky‐Zeichner(The University of Texas Health Science Center), Betts Rf, L. Arnold, J M De la Vega Vázquez, Byungse Suh(Temple University), Márcio Nucci(Universidade Federal do Rio de Janeiro), Chunzhang Wu(Astellas Pharma (Japan)), Jan J. De Waele(Ghent University Hospital)
Ghent University Academic Bibliography (Ghent University)
January 1, 2008
Cited by 131
Related Papers
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2008|3.2k
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k